標(biāo)題: Titlebook: Nanomedicine; Principles and Persp Yi Ge,Songjun Li,Richard Moore Book 2014 Springer Science+Business Media New York 2014 Biotechnology.Med [打印本頁(yè)] 作者: duodenum 時(shí)間: 2025-3-21 17:41
書目名稱Nanomedicine影響因子(影響力)
書目名稱Nanomedicine影響因子(影響力)學(xué)科排名
書目名稱Nanomedicine網(wǎng)絡(luò)公開度
書目名稱Nanomedicine網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Nanomedicine被引頻次
書目名稱Nanomedicine被引頻次學(xué)科排名
書目名稱Nanomedicine年度引用
書目名稱Nanomedicine年度引用學(xué)科排名
書目名稱Nanomedicine讀者反饋
書目名稱Nanomedicine讀者反饋學(xué)科排名
作者: Irrigate 時(shí)間: 2025-3-22 00:05
Nanobiology in Medicine,gan system, but each of them follow specific nanoscale processes in order to generate and drive life. In most of the eukaryotic cells, the basic unit of genetic information is the DNA (Deoxyribonucleic acid), which falls under nanometric regime (~2.5 nm). The exploration of life in our mother earth 作者: 單挑 時(shí)間: 2025-3-22 02:16
Tissue Engineering , with Nanotechnology,eatures on the macro scale. Nanomaterials open up the possibility for more surface area for cell-surface interactions, the possibility of making stronger scaffolds for tissue re-growth, and the prospect to self-assemble nanostructures which will resemble cellular structures already found in the body作者: POLYP 時(shí)間: 2025-3-22 08:16
Nanomaterial Design and Computational Modeling,vestigate mechanisms of phenomena and even to design artificial structures in order to get desirable properties. This chapter presents theoretical frameworks of three most widely-used atomistic simulation methods: first-principles, tight binding and molecular dynamics, as well as some detailed demon作者: 戰(zhàn)勝 時(shí)間: 2025-3-22 12:35
Multifunctional Nanoparticles for Theranostics and Imaging,noparticle is the foundation to employ nanostructures possible for theranostics in nanomedicine. The attractive features to nanoparticles (NPs) can result in several advantageous strategies including both drug(s) and imaging agent(s) encapsulated within an individual nanoparticle for simultaneous di作者: glucagon 時(shí)間: 2025-3-22 14:40
Medical Nanobiosensors,as ELISA and PCR) report different handicaps including high cost and time consuming labors. In this regard, novel advances in diagnostic technology are highly desired. Biosensors are useful devices that enable the detection of molecules with diagnostic interest. Since nanotechnology enables the mani作者: blister 時(shí)間: 2025-3-22 17:48
Nanotechnology in Advanced Medical Devices,utionising advanced medical devices. It is important to note that the World Health Organisation’s definition of medical devices includes examples that are counterintuitive but must be examined, this involves a large range of devices that can be categorised in the fields of imaging, biosensors and su作者: CERE 時(shí)間: 2025-3-22 21:26 作者: ILEUM 時(shí)間: 2025-3-23 03:40
Pharmaceutical Nanotechnology: Overcoming Drug Delivery Challenges in Contemporary Medicine,rugs. Poor biopharmaceutical characteristics of drug and biological barriers in the body affect the drug molecules reaching the intended disease site. For instance, solubility and permeability of a drug molecule affect its transport through the cellular membranes, while their stability in the biolog作者: Vertebra 時(shí)間: 2025-3-23 09:22
Harmful or Helpful, the Toxicity and Safety of Nano-sized Medicine,apeutic agents for drug delivery or imaging where their enhanced properties, due to their size and reactivity, have benefits over bulk materials; however there is a high degree of uncertainty about their potential adverse effects and exposure both to humans and the environment which must be addresse作者: 能得到 時(shí)間: 2025-3-23 11:03
Ethical Implications of Nanomedicine: Implications of Imagining New Futures for Medicine,an body. While these are usually enabling technologies, they already embody values and imply trajectories for future medicine which raise important questions. In enabling a move to pre-symptomatic medicine, nano-diagnostics may revolutionise some treatments, but also pose problems. Do we want advanc作者: 無(wú)能力之人 時(shí)間: 2025-3-23 17:34
Nanomedicine: A Hyper-expectation and Dawning Realisation?,entality has escalated to the degree that such advancement is expected in increasing instalments with the passage of time. Nanomedicine is not exempt from this expectation nor has it disappointed thus far as any review of the literature will demonstrate. There is however a significant separation bet作者: conduct 時(shí)間: 2025-3-23 19:02
Nanomedicine as a Business Venture,on, which is essential for translation to the clinic. In Europe, such translation from excellence of science is a major area of priority to the different member states and the European Commission in order to establish a profitable and industrial nanomedicine sector. The current regulatory landscape 作者: BRAVE 時(shí)間: 2025-3-24 01:12
What Can Nanomedicine Learn from the Current Developments of Nanotechnology?,ology could thus greatly influence the developments of nanomedicine. In recent years, the research and development in nanomedicine have received enormous attentions and interests from industry, academia, government and society, due to its enormous capability to provide unique benefits and great adva作者: 水土 時(shí)間: 2025-3-24 04:55 作者: 微枝末節(jié) 時(shí)間: 2025-3-24 07:09
The Impact of Nanopharmaceuticals on Healthcare and Regulation,, which covers discovery, development, and delivery of drug. With the unique and advanced properties offered by nanomaterials, the drug delivery systems and other therapeutic methods have been improved with great significance, providing efficient solutions toward various clinical conundrums, and shi作者: 控訴 時(shí)間: 2025-3-24 13:21 作者: adhesive 時(shí)間: 2025-3-24 15:16
Challenges to Nanomedicine,already having an impact across almost all medical product sectors and medical specialisms. While the pipeline of products implementing nanotechnology in some form is already significant with many times more at an earlier stage of research and development, it is useful to review those steps a potent作者: 1FAWN 時(shí)間: 2025-3-24 21:26 作者: 假設(shè) 時(shí)間: 2025-3-25 00:39
Steven D. Perraultcademic researcher with practical testbed for popular theore.This monograph focuses on control methods that influence vehicle dynamics to assist the driver in enhancing passenger comfort, road holding, efficiency and safety of transport, etc., while maintaining the driver’s ability to override that 作者: 解開 時(shí)間: 2025-3-25 07:13 作者: 復(fù)習(xí) 時(shí)間: 2025-3-25 09:39 作者: 颶風(fēng) 時(shí)間: 2025-3-25 12:10
Sabeeh Habib-Ullah,Dan Fei,Yi Gecy and safety of transport, etc., while maintaining the driver’s ability to override that assistance. On individual-vehicle-component level the control problem is formulated and solved by a unified modelling and design method provided by the linear parameter varying (LPV) framework. The global behav作者: forecast 時(shí)間: 2025-3-25 17:08
Soichiro Tottori,Li Zhang,Bradley J. Nelsoncy and safety of transport, etc., while maintaining the driver’s ability to override that assistance. On individual-vehicle-component level the control problem is formulated and solved by a unified modelling and design method provided by the linear parameter varying (LPV) framework. The global behav作者: genuine 時(shí)間: 2025-3-25 22:36
Srinivas Ganta,Amit Singh,Timothy P. Coleman,David Williams,Mansoor Amijihabe, die, dem beschr?nkten Kreise des Familienlebens enthoben, in der historisch und politisch offenbar gewordenen Entfaltung eines Moments in der V?lkergeschichte ihre Basis sucht. Abgesehen von der Irrthümlichkeit dieser Meinung, in W. Scott den ersten Bebauer eines Feldes der Dichtkunst finden z作者: indenture 時(shí)間: 2025-3-26 03:33
Sophie A. Rocks,Huijun Zhu,Robert Dorey,Philip Holmesche von 70 m. in sich (. 1963). T?glich passieren 20000 Liter Atemluft das Bronchialsystem und die Alveolen. Atemluft und Blut sind durch eine maximal 0,5 μ dicke Kapillarmembran voneinander getrennt. Diese an Quantit?t und Qualit?t ?u?erst enge Beziehung zwischen der Umwelt und dem Organ(-ismus) er作者: Inveterate 時(shí)間: 2025-3-26 07:36 作者: ACRID 時(shí)間: 2025-3-26 12:21 作者: rheumatology 時(shí)間: 2025-3-26 15:20
Olivier Fontaine,Bojan Boskovic,Yi Ges software systems, the commercial S-PLUS? and the Open..Source R. This book provides an in-depth guide to writing software in..the S language under either or both of those systems. It is intended..for readers who have some acquaintance with the S language and want to..know how to use it more effect作者: In-Situ 時(shí)間: 2025-3-26 20:04
Sirikanya Chokaouychai,Dan Fei,Yi Ge the basis of rather short contacts between the seLenium atoms in two adjacent thiodisetenazyl rings (see .). The [SN.Se.]. cation in [SN.Se.AsF.]. has slightly asymmetric interactions between the two thiodiselenazyl rings and does not have crystallographic inversion symmetry. The diseLenide bonds i作者: 乳汁 時(shí)間: 2025-3-26 22:16 作者: growth-factor 時(shí)間: 2025-3-27 02:02
Rebecca Zhangqiuzi Fan,Dan Fei,Roberta D’Aurelio,Yi Gelfur and nitrogen. At least one sulfur atom can be regarded as having oxidation number IV in one resonance structure. That means the sulfur in fact has an oxidation number higher than 11 and lower than VI. The volume continues "Sulfur-Nitrogen Compounds" Part 2, in which the binary sulfur(lV)-nitrog作者: 得意牛 時(shí)間: 2025-3-27 09:06
Maya Thanou,Andrew D. MillerN compounds are arranged according to the coordination number of the sulfur. Neutral compounds are described before ions and complex compounds. The preceding series "Sulfur-Nitrogen Compounds" Parts 2, 3, and 4 covers the cyclic sw-N compounds. In this volume, the first section deals with sulfur-nit作者: 高興一回 時(shí)間: 2025-3-27 11:09
Richard Moores are arranged according to the coordination number of the sulfur. Neutral compounds are described before ions and complex compounds. The preceding series "Sulfur-Nitrogen Compounds" Parts 2, 3, and 4 covers the cyclic sw-N compounds. In this volume, the first section deals with sulfur-nitrogen comp作者: Infantry 時(shí)間: 2025-3-27 16:39 作者: 一起 時(shí)間: 2025-3-27 20:40
Nanomedicine978-1-4614-2140-5Series ISSN 1571-5744 Series E-ISSN 2197-7976 作者: 凌辱 時(shí)間: 2025-3-28 01:26 作者: 吊胃口 時(shí)間: 2025-3-28 05:33
Yi Ge,Songjun Li,Richard MooreUp-to-date, in-depth, and integrated knowledge of nanotechnology applications to medicine.Academia, industry, government agencies, and the health care system all represented among the contributors.The作者: 正式演說(shuō) 時(shí)間: 2025-3-28 08:26
Nanostructure Science and Technologyhttp://image.papertrans.cn/n/image/660834.jpg作者: 圖表證明 時(shí)間: 2025-3-28 11:40 作者: LITHE 時(shí)間: 2025-3-28 15:33
Nanotechnology in Advanced Medical Devices,rgery. It is also germane to evaluate how academia, industry and government regulations are using legislative protocols to mitigate the associated risks. This chapter intends to review the field of advanced medical devices utilizing nanotechnology together with a discussion on its impact on health and medicine.作者: 不給啤 時(shí)間: 2025-3-28 21:34
Intersection of Nanotechnology and Healthcare, fair share of toxicity and regulatory issues and even public acknowledgement to deal with. Nevertheless, the future of healthcare would be closely interlinked with developments in nanotechnology which is being used in an evolutionary manner to improve and/or replace many therapeutics and healthcare products.作者: intertwine 時(shí)間: 2025-3-28 23:02
Nanomedicine: Revolutionary Interdiscipline,ct subsections: nanobiotechnology, nanotechnology and nanobiomimetics, and also through the two main synthetic approaches, top-down and bottom-up, both of which are pivotal in separating the enhancement of existing technology from the development of revolutionary new technology.作者: Ethics 時(shí)間: 2025-3-29 05:52
Tissue Engineering , with Nanotechnology,tissue repair, guide nerve re-growth, eradicate infections, and reduce post injury inflammation. The following chapter will discuss several important aspects of the impact of nanotechnology on various tissue engineering applications by focusing on . animal studies, a necessary step forward towards the next generation of nanomedicine.作者: 親密 時(shí)間: 2025-3-29 10:34 作者: bile648 時(shí)間: 2025-3-29 13:52
Medical Nanobiosensors, we describe the basic principles of the nanobiosensors and discuss different nanobiosensing strategies towards medical applications focused on three categories: neurodegenerative diseases, cardiovascular diseases and cancer.作者: LIMIT 時(shí)間: 2025-3-29 17:38 作者: 小木槌 時(shí)間: 2025-3-29 21:17
Book 2014undamentals of new applications and products of nanomedicine, as well as an outlook for the future. This book can well serve as a reference and guide for students, academics, researchers, scientists, engineers, clinicians, government researchers, and healthcare professionals..作者: 控制 時(shí)間: 2025-3-30 01:29
Nanobiology in Medicine,y and medicine are studied with diverse viewpoints. This chapter aims to offer an overview about what nanobiology is and how it is facilitating and impacting on the current developments and trends in medicine.作者: PUT 時(shí)間: 2025-3-30 07:42
Harmful or Helpful, the Toxicity and Safety of Nano-sized Medicine,le decision making. Here we summarise the recent research into the toxicity of engineered nanomaterials, the current understanding of the different regulatory approaches that are applicable to the healthcare industry in particular and highlights areas of concern that require addressing within the near future.作者: 把…比做 時(shí)間: 2025-3-30 10:21
Nanomedicine: A Hyper-expectation and Dawning Realisation?,e development of the concept and its assimilation into medicine. In this way, both hyper-expectation and dawning realisation stand side by side to create this unique and highly dynamic time of the implementation of nanomedicine to reality of practiced clinical medicine.作者: anaerobic 時(shí)間: 2025-3-30 12:57 作者: carbohydrate 時(shí)間: 2025-3-30 19:24 作者: 隼鷹 時(shí)間: 2025-3-30 21:28 作者: separate 時(shí)間: 2025-3-31 00:52
Book 2014linary area - nanomedicine. This book offers comprehensive knowledge of and diverse perspectives on nanomedicine through two independent volumes. It aims to bridge the gap between nanotechnology and medicine through contributions by world-renowned experts from wide range of backgrounds including aca作者: 同義聯(lián)想法 時(shí)間: 2025-3-31 06:06 作者: 阻塞 時(shí)間: 2025-3-31 12:11 作者: overrule 時(shí)間: 2025-3-31 13:50
Eden Morales-Narváez,Arben Merko?i active driver assistance;.formulation and solution proposals for the integrated vehicle control problem;.proposal for a reconfigurable and fault-tolerant control architecture;.formulation and solution proposals for the plug-and-play concept;.detailed case studies..Robust Control Design for Active V作者: 易達(dá)到 時(shí)間: 2025-3-31 20:45 作者: 遺傳 時(shí)間: 2025-3-31 21:56
Soichiro Tottori,Li Zhang,Bradley J. Nelson active driver assistance;.formulation and solution proposals for the integrated vehicle control problem;.proposal for a reconfigurable and fault-tolerant control architecture;.formulation and solution proposals for the plug-and-play concept;.detailed case studies..Robust Control Design for Active V作者: 網(wǎng)絡(luò)添麻煩 時(shí)間: 2025-4-1 02:20
Srinivas Ganta,Amit Singh,Timothy P. Coleman,David Williams,Mansoor Amijintfalten, was treue Auffassung der n?chsten Wirklichkeit und emsige Nachbildung der blanken, baaren Natürlichkeit zu erreichen vermag. Eine Poesie, die aus der ewig frischen und lebendigen Fülle v?lkergeschichtlicher Begebenheiten ihre Stoffe entlehnt, wird allerdings nicht so leicht und so tief in 作者: Metamorphosis 時(shí)間: 2025-4-1 06:57 作者: FLOUR 時(shí)間: 2025-4-1 12:54
Donald Bruceoproteinhaltigen Schleim. Das mukoziliare Transportsystem bef?rdert inhalierte Teilchen mit einer Gr??e von 2–10 μ oralw?rts. Die oberfl?chenaktive Substanz der Alveolen (surfactant) entfaltet eine protektive Wirkung durch Phospholipide, Proteine und Immunglobuline der Klasse IgG. Die systemischen M作者: fructose 時(shí)間: 2025-4-1 18:06
